US20030215798A1
(en)
*
|
1997-06-16 |
2003-11-20 |
Diversa Corporation |
High throughput fluorescence-based screening for novel enzymes
|
US5880972A
(en)
*
|
1996-02-26 |
1999-03-09 |
Pharmacopeia, Inc. |
Method and apparatus for generating and representing combinatorial chemistry libraries
|
US20030054543A1
(en)
*
|
1997-06-16 |
2003-03-20 |
Lafferty William Michael |
Device for moving a selected station of a holding plate to a predetermined location for interaction with a probe
|
US20050070005A1
(en)
*
|
1997-06-16 |
2005-03-31 |
Martin Keller |
High throughput or capillary-based screening for a bioactivity or biomolecule
|
US20020102598A1
(en)
*
|
1997-06-16 |
2002-08-01 |
Lafferty William Michael |
Positioning system for moving a selected station of a holding plate to a predetermined location for interaction with a probe
|
US20040241759A1
(en)
*
|
1997-06-16 |
2004-12-02 |
Eileen Tozer |
High throughput screening of libraries
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
WO2000031536A2
(en)
*
|
1998-11-23 |
2000-06-02 |
President And Fellows Of Harvard College |
Detecting structural or synthetic information about chemical compounds
|
US6254835B1
(en)
|
1999-03-31 |
2001-07-03 |
Pharmacopeia, Inc. |
Methods and apparatus for improved fluid control utilizing a u-valve employing a bidirectional check valve
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
WO2001059450A2
(en)
|
2000-02-08 |
2001-08-16 |
Sangamo Biosciences, Inc. |
Cells expressing zinc finger protein for drug discovery
|
WO2001083819A2
(en)
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Methods for designing exogenous regulatory molecules
|
US7923542B2
(en)
|
2000-04-28 |
2011-04-12 |
Sangamo Biosciences, Inc. |
Libraries of regulatory sequences, methods of making and using same
|
US20020064802A1
(en)
|
2000-04-28 |
2002-05-30 |
Eva Raschke |
Methods for binding an exogenous molecule to cellular chromatin
|
AU2001257421A1
(en)
|
2000-04-28 |
2001-11-12 |
Sangamo Biosciences, Inc. |
Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
|
EP1276860B1
(en)
|
2000-04-28 |
2007-09-26 |
Sangamo Biosciences Inc. |
Databases of regulatory sequences; methods of making and using same
|
ES2316446T3
(es)
|
2000-04-29 |
2009-04-16 |
University Of Iowa Research Foundation |
Diagnostico y terapeutica para trastornos relacionados con la degeneracion macular.
|
AU2001296846B2
(en)
|
2000-10-12 |
2007-07-05 |
University Of Rochester |
Compositions that inhibit proliferation of cancer cells
|
US7378280B2
(en)
|
2000-11-16 |
2008-05-27 |
California Institute Of Technology |
Apparatus and methods for conducting assays and high throughput screening
|
US20040241650A1
(en)
*
|
2001-01-19 |
2004-12-02 |
Evans Glen A |
Computer-directed assembly of a polynucleotide encoding a target polypeptide
|
EP1406493A4
(en)
|
2001-06-11 |
2006-06-14 |
Xenoport Inc |
ADMINISTRATION OF MEDIUM BY THE PEPT-2 TRANSPORTER
|
WO2002102820A1
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
DE10147074A1
(de)
*
|
2001-09-25 |
2003-05-08 |
Beru Ag |
Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
|
US7811992B2
(en)
|
2002-02-06 |
2010-10-12 |
Stasys Technologies, Inc. |
Anti-infarction molecules
|
IL163822A0
(en)
|
2002-03-15 |
2005-12-18 |
Nuevolution As |
An improved method for synthesising templated molecules
|
WO2004013070A2
(en)
*
|
2002-08-01 |
2004-02-12 |
Nuevolution A/S |
Multi-step synthesis of templated molecules
|
CA2495478A1
(en)
|
2002-08-05 |
2004-02-12 |
University Of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
PT1558744E
(pt)
|
2002-10-30 |
2011-09-22 |
Nuevolution As |
Codificação enzimática
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
WO2008103472A2
(en)
|
2007-02-23 |
2008-08-28 |
Elan Pharmaceuticals, Inc. |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
BR0316737A
(pt)
|
2002-11-27 |
2005-12-13 |
Irm Llc |
Métodos e composições para induzir apoptose em células cancerosas
|
ATE450609T1
(de)
*
|
2002-12-19 |
2009-12-15 |
Nuevolution As |
Durch quasizufallsstrukturen und funktionen geführte synthesemethode
|
WO2004069182A2
(en)
|
2003-02-01 |
2004-08-19 |
Neuralab Limited |
Active immunization to generate antibodies to soluble a-beta
|
EP1597395A2
(en)
|
2003-02-21 |
2005-11-23 |
Nuevolution A/S |
Method for producing second-generation library
|
ES2640669T3
(es)
|
2003-05-19 |
2017-11-03 |
Prothena Biosciences Limited |
Fragmentos truncados de alfa-sinucleína en enfermedad con cuerpos de lewy
|
US7358331B2
(en)
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
US8153410B2
(en)
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
US20060162014A1
(en)
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
EP1670939B1
(en)
|
2003-09-18 |
2009-11-04 |
Nuevolution A/S |
A method for obtaining structural information concerning an encoded molecule and method for selecting compounds
|
PL2336147T3
(pl)
|
2003-12-17 |
2015-01-30 |
Janssen Alzheimer Immunotherap |
Immunogenne koniugaty A beta z nośnikiem peptydowym i sposoby ich otrzymywania
|
HUE026000T2
(en)
|
2003-12-17 |
2016-04-28 |
Wyeth Llc |
Immunogenic peptide-bearing conjugates and methods for their preparation
|
WO2005078122A2
(en)
*
|
2004-02-17 |
2005-08-25 |
Nuevolution A/S |
Method for enrichment involving elimination by mismatch hybridisation
|
US7572600B2
(en)
|
2004-08-04 |
2009-08-11 |
Chemocentryx, Inc. |
Enzymatic activities in chemokine-mediated inflammation
|
MX2007001679A
(es)
|
2004-08-09 |
2007-05-23 |
Elan Pharm Inc |
Prevencion y tratamiento de la enfermedad sinucleinopatica y amiloidogenica.
|
WO2006018277A1
(en)
*
|
2004-08-17 |
2006-02-23 |
Universität Bern |
Method for rational combinatorial synthesis
|
US8088579B2
(en)
|
2005-02-14 |
2012-01-03 |
University Of Iowa Research Foundation |
Complement factor H for diagnosis of age-related macular degeneration
|
US8076090B2
(en)
|
2005-04-05 |
2011-12-13 |
Corning Incorporated |
Label free biosensors and cells
|
EP2371843B1
(en)
|
2005-05-19 |
2014-09-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services |
Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
|
WO2007030560A2
(en)
|
2005-09-08 |
2007-03-15 |
Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine |
Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents
|
EP1934331A4
(en)
|
2005-10-14 |
2009-01-21 |
Musc Found For Res Dev |
PAX2 AS A TARGET FOR THE INDUCTION OF DEFB1-MEDIATED TUMORIMMUNITY AND CANCER THERAPY
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
DE602006018648D1
(de)
|
2005-12-01 |
2011-01-13 |
Nuevolution As |
Enzymvermittelnde kodierungsmethoden für eine effiziente synthese von grossen bibliotheken
|
EP2035448A4
(en)
|
2006-06-01 |
2010-11-03 |
Elan Pharm Inc |
NEUROACTIVE FRAGMENTS OF APP
|
CA2664189C
(en)
|
2006-09-21 |
2017-11-21 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic dystrophy
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
WO2008085794A2
(en)
|
2007-01-03 |
2008-07-17 |
Burnham Institute For Medical Research |
Methods and compositions related to clot binding compounds
|
WO2008098182A1
(en)
|
2007-02-08 |
2008-08-14 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
PT3067066T
(pt)
|
2007-02-23 |
2019-06-17 |
Univ California |
Prevenção e tratamento da doença sinucleinopática e amiloidogénica
|
US8779088B2
(en)
|
2007-12-17 |
2014-07-15 |
Marfl Ab |
Vaccine for the treatment of Mycobacterium related disorders
|
NZ586875A
(en)
|
2007-12-28 |
2012-10-26 |
Elan Pharm Inc |
Treatment and prophylaxis of amyloidosis with an antibody that binds a specific epitope of human amyloid A peptide
|
CA2713423A1
(en)
|
2008-01-18 |
2009-07-23 |
North Carolina State University |
Peptides and methods of use as therapeutics and screening agents
|
AU2009281732A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
CA2734892A1
(en)
|
2008-08-18 |
2010-02-25 |
Seoul National University Industry Foundation |
Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase
|
EP2370080A1
(en)
|
2008-12-02 |
2011-10-05 |
University of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
EP2789618B1
(en)
|
2008-12-03 |
2016-07-27 |
The Scripps Research Institute |
Stem cell cultures
|
WO2010148365A2
(en)
|
2009-06-19 |
2010-12-23 |
The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona For And On Behalf Of Arizona State University |
Compound arrays for sample profiling
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
EP2485768A1
(en)
|
2009-10-07 |
2012-08-15 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
EP2512497A1
(en)
|
2009-12-18 |
2012-10-24 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding compounds
|
ES2713873T3
(es)
|
2010-04-16 |
2019-05-24 |
Nuevolution As |
Complejos bifuncionales y métodos para hacer y utilizar tales complejos
|
CA2868735C
(en)
|
2011-03-28 |
2020-02-25 |
University Of Utah Research Foundation |
D-peptide conjugates comprising a membrane localizing potency-enhancing cargo molecule for inhibiting hiv entry
|
US8975293B2
(en)
|
2011-05-26 |
2015-03-10 |
Regents Of The University Of Michigan |
Epigenetic co-repressors of the gamma-globin gene and methods of using same
|
JP6166263B2
(ja)
|
2011-09-22 |
2017-07-19 |
メディシナル バイオコンバージェンス リサーチ センター |
ロイシンtRNA合成酵素の新規用途(NoveluseofleucyltRNAsynthetase)
|
WO2013044029A1
(en)
|
2011-09-23 |
2013-03-28 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for expanding cells and improving engraftment
|
KR101398079B1
(ko)
|
2011-10-10 |
2014-05-27 |
재단법인 의약바이오컨버젼스연구단 |
글리실-티알엔에이 합성효소 및 캐드헤린을 이용한 암 예방 또는 치료제의 스크리닝 방법
|
WO2013078138A1
(en)
|
2011-11-21 |
2013-05-30 |
OSI Pharmaceuticals, LLC |
Proton nmr spectroscopy for biochemical screening
|
US10006919B2
(en)
|
2013-03-15 |
2018-06-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Peptide array quality control
|
US9970932B2
(en)
|
2013-03-15 |
2018-05-15 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Non-covalent patterned chemical features and use thereof in MALDI-based quality control
|
EP3191526B1
(en)
|
2014-09-12 |
2023-02-22 |
The Board of Trustees of the Leland Stanford Junior University |
Wnt signaling agonist molecules
|
EP3234111A1
(en)
|
2014-12-19 |
2017-10-25 |
Regeneron Pharmaceuticals, Inc. |
Stem cells for modeling type 2 diabetes
|
CA2983351A1
(en)
|
2015-04-20 |
2016-10-27 |
F. Hoffmann-La Roche Ag |
Specific peptide binders to proteins identified via systemic discovery, maturation and extension process
|
US10758886B2
(en)
|
2015-09-14 |
2020-09-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Conditioned surfaces for in situ molecular array synthesis
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
AU2017281039A1
(en)
|
2016-06-20 |
2019-01-24 |
Healthtell Inc. |
Methods for differential diagnosis of autoimmune diseases
|
AU2017281040A1
(en)
|
2016-06-20 |
2019-01-24 |
Healthtell Inc. |
Methods for diagnosis and treatment of autoimmune diseases
|
KR20190025689A
(ko)
|
2016-07-06 |
2019-03-11 |
프로테나 바이오사이언시즈 리미티드 |
전체 및 s129 인산화된 알파-시누클레인을 검출하기 위한 검정
|
US10548302B2
(en)
|
2016-07-29 |
2020-02-04 |
Regeneron Pharmaceuticals, Inc. |
Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy
|
MA46523A
(fr)
|
2016-10-12 |
2019-08-21 |
Janssen Biotech Inc |
Procédés de criblage de modulateurs d'une activité biologique de type gdf15
|
AU2017357818A1
(en)
|
2016-11-11 |
2019-05-30 |
HealthTell, Inc. |
Methods for identifying candidate biomarkers
|
WO2018202850A1
(en)
|
2017-05-05 |
2018-11-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
|
US20200209241A1
(en)
|
2017-09-15 |
2020-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
CA3076371C
(en)
|
2017-11-10 |
2022-11-22 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising slc30a8 mutation and methods of use
|
AU2019304526A1
(en)
|
2018-07-20 |
2020-12-24 |
Aicuris Gmbh & Co. Kg |
Methods for screening and identifying agents that inhibit or modulate the nuclear egress complex of herpesviruses
|
CA3136119A1
(en)
|
2019-04-10 |
2020-10-15 |
University Of Utah Research Foundation |
Htra1 modulation for treatment of amd
|
EP4038222A4
(en)
|
2019-10-02 |
2023-10-18 |
Arizona Board of Regents on behalf of Arizona State University |
METHODS AND COMPOSITIONS FOR IDENTIFYING NEOANTIGENS FOR USE IN THE TREATMENT AND PREVENTION OF CANCER
|